What Owkin does
Owkin is an AI company focused on biopharmaceutical research and development. It builds AI technology that connects research and patient care, aiming to accelerate drug discovery and clinical research, particularly in oncology.
Key capabilities
Owkin's flagship product, K Pro, is described as an AI agent that delivers insights across drug discovery and clinical research. Its capabilities include target identification, patient population analysis, clinical trial decision support, early portfolio assessment, and real-world data integration. The AI is trained on multimodal patient data, validated through lab infrastructure, and refined with input from oncologists and biologists.
Who it's for
Owkin primarily serves pharmaceutical companies and clinical research organizations that want to accelerate insights in drug development. It also partners with hospitals and patient networks as data providers, building a feedback loop that connects research directly to clinical decision-making.